| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Director | Stock Option (right to buy Common Stock) | 50,000 | 02 May 2025 | Direct | ||
| Notable Labs, Ltd. | Director | Ordinary Shares | 40,247 | 08 May 2024 | Direct | ||
| Notable Labs, Ltd. | Director | Stock Option | 9,753 | 24 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INTS | INTENSITY THERAPEUTICS, INC. | 02 May 2025 | 1 | $0 | 4 | Director | 06 May 2025, 16:11 |
| INTS | INTENSITY THERAPEUTICS, INC. | 14 May 2024 | 1 | $0 | 4 | Director | 15 May 2024, 16:35 |
| INTS | INTENSITY THERAPEUTICS, INC. | 14 May 2024 | 0 | $0 | 3 | Director | 15 May 2024, 16:31 |
| /report/000106299324009933-dubin-thomas-i-h-2024-05-08 | Notable Labs, Ltd. | 08 May 2024 | 1 | $0 | 4 | Director | 10 May 2024, 17:09 |
| /report/000106299324001359-dubin-thomas-i-h-2024-01-24 | Notable Labs, Ltd. | 24 Jan 2024 | 1 | $0 | 4 | Director | 26 Jan 2024, 11:02 |
| /report/000106299323019516-dubin-thomas-i-h-2023-10-16 | Notable Labs, Ltd. | 16 Oct 2023 | 0 | $0 | 3 | Director | 18 Oct 2023, 08:40 |